Evolution of policy for the treatment of substance use disorders in Qatar

被引:0
|
作者
Majid Alabdulla
Nimesh Samarasinghe
Iain Tulley
Shuja Reagu
机构
[1] Mental Health Services,
[2] Hamad Medical Corporation,undefined
[3] College of Medicine,undefined
[4] Qatar University,undefined
[5] Weill Cornell Medicine,undefined
关键词
Qatar; Middle East North Africa; Substance abuse policy; Mental health;
D O I
暂无
中图分类号
学科分类号
摘要
There is a marked paucity of published evidence on the extent and nature of substance use disorders in the State of Qatar. This is mirrored by a dearth of information on the policy for the treatment of substance use disorders in the public domain. Between 2007 and 2017, substance use disorders have risen from the third to leading cause of disability in Qatar. More recently, Qatar has shifted from applying a punitive only paradigm in managing substance use problems to recognizing the role of treatment and care for people with substance use disorders. Recently published official documents in Qatar define addiction as a disease and as a chronic condition where people with substance use disorders should be treated as patients who need care and assistance. This shifts the onus of providing, and developing services, for individuals with substance use disorders with healthcare providers rather than purely with the criminal justice system. Following cabinet approval, the recently established Permanent Committee for Addiction Treatment headed by the Minister of Public Health, signals the need to institutionalize systems and structures to upscale demand reduction programmes in the country. This article is a descriptive examination of the shifts in substance abuse treatment policy in Qatar, the major factors influencing this evolution, and will utilise some of the policy science theories to describe and analyse policy outcomes. The article will also frame the substance use problem in Qatar for the first time, based on documents published by various government organisations.
引用
收藏
相关论文
共 50 条
  • [41] Integrated Treatment of Substance Use and Psychiatric Disorders
    Kelly, Thomas M.
    Daley, Dennis C.
    SOCIAL WORK IN PUBLIC HEALTH, 2013, 28 (3-4) : 388 - 406
  • [42] Hepatitis C treatment and substance use disorders
    Fireman, M
    PSYCHIATRIC ANNALS, 2003, 33 (06) : 402 - 408
  • [43] Pharmacological Treatment of Youth Substance Use Disorders
    Squeglia, Lindsay M.
    Fadus, Matthew C.
    McClure, Erin A.
    Tomko, Rachel L.
    Gray, Kevin M.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2019, 29 (07) : 559 - 572
  • [44] Hispanics in specialty treatment for substance use disorders
    Reif, Sharon
    Horgan, Constance M.
    Ritter, Grant A.
    JOURNAL OF DRUG ISSUES, 2008, 38 (01) : 311 - 333
  • [45] Integrated treatment for mood and substance use disorders
    Rounsaville, BJ
    ADDICTION, 2004, 99 (02) : 266 - 267
  • [46] Integrated treatment for mood and substance use disorders
    Ruiz, P
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (08) : 1151 - 1151
  • [47] Integrated Treatment for Mood and Substance Use Disorders
    el-Guebaly, Nady
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2004, 49 (08): : 571 - 571
  • [48] Abstinence or maintenance treatment in substance use disorders?
    Walter, Marc
    Soyka, Michael
    ADDICTION, 2016, 111 (05) : 775 - 776
  • [49] Exploring policy challenges and options: Improving treatment for adolescents with substance use disorders - Editors' introduction
    Cavanaugh, DA
    Kraft, MK
    JOURNAL OF PSYCHOACTIVE DRUGS, 2004, 36 (04) : 411 - 413
  • [50] Substance Use Disorders Refresh: Nonopioid Substance Use Disorders
    Zhao, Nan
    Jorgensen, Shea
    Dixon, Lisa B.
    PSYCHIATRIC SERVICES, 2023, 74 (09) : 1006 - 1007